Monthly Newsletter June 2017

ACSMEDI-EFMC: Medicinal Chemistry Frontiers 2017, June 25-28, 2017 - Discover the Final Scientific Programme

The sixth edition of the conference again brings together medicinal chemists from around the world to share new and exciting results. Check the final Scientific Programme.

The Scientific Programme for Frontiers 2017 will feature sessions covering the latest advances in medicinal chemistry. Session topic areas include:

    Small Molecule Modulators of RNA
    Positive Allosteric Modulators
    Biased Agonism in GPCRs
    Targeting Regulated Cell Death
    Drug Discovery in Academia
    The Latest in Antivirals
    IO and Epigenetics in Treating Cancer

The programme will be complemented by a poster session, a commercial exhibition and  social events. Poster presentations from postdoctoral and graduate students will be considered for two poster prizes, from J. Med. Chem. and ACS Med. Chem. Letters, each worth $200. Those selected will give a 10 minute talk on their poster during the Wednesday morning session.

Attractive lodging rates at the newly renovated venue (Downtown Sheraton, 17th Street Philadelphia) have been negotiated by the organisers and can be booked on the accomodation page.

We hope to see you in Philadelphia this June!

Find out more on

4th EFMC Young Medicinal Chemist Symposium - Keynote lectures announced!

The programme of the 4th EFMC Young Medicinal Chemist Symposium will include two keynote lectures from inspiring leaders in the field of Medicinal Chemistry.

Dr Christoph BOSS (Actelion Pharmaceuticals, Switzerland) will give a lecture on the Fascinating World of Medicinal Chemistry and Drug Discovery while Dr Peter NUSSBAUMER (Lead Discovery Center, Germany) will talk on Challenging Medicinal Chemistry!

Perhaps even more importantly the event is a show case for young talent and the programme will also include: 15 oral communications by invited prize winners from national young medicinal chemist competitions in Europe; 3 oral communications selected from submitted abstracts; 20 flash poster presentations selected from submitted abstracts; and a poster session open to any young researcher submitting an abstract.

The programme to-date is available here.

This year again, there are prizes to be won for the best Oral Communication & best Poster - selected by a jury, and to the best Presentation - voted by the public. More information on the Prizes can be found here.

If you have not yet registered, we advise you to do it quickly as the deadline for Early-Bird fee, and for abstract submission for Oral Communication is June 6!

Find out more on the EFMC-YMCS website

9th Summer School on Drug Design - September 17-22, 2017 - University of Vienna, Austria

The summer school focuses on students and professionals with a clear interest in learning the basics as well as latest developments in Pharmacoinformatics. This year the program has put an emphasis on open innovation as well as on computational technologies used for the kinetics of ligand binding. During the afternoon sessions, the participants will have the opportunity to obtain hands-on training.

Topics include:

  • Multitarget Profiling and Integrated Approaches
  • Chemical Similarity and Biological Activity
  • Structure and Function of Biomolecules
  • Ligand- and Target-based Design
  • Pharmacophore Modelling
  • Open Data, Open Tools, Open Knowledge
  • Kinetics of Ligand Binding
  • Case Studies from Industry

Click here for more information on the programme

Click here to register to the Summer School

If you have any questions regarding the EUROPIN Summer School on Drug Design, please don't hesitate to contact us at

Summer School in Pharmaceutical Analysis (SSPA) – 2017, September 18-20, 2017 - Rimini, Italy

The Summer School in Pharmaceutical Analysis (SSPA) is organised by the Intradivisional group of Pharmaceutical Analysis, Division of Medicinal Chemistry, Italian Chemical Society (SCI) and sponsored by the European Federation for Medicinal Chemistry (EFMC).

SSPA is mainly addressed to researchers and PhD students focusing on the different aspects of analysis in drug discovery & development and in drug manufacturing. The course is open to a maximum of 80 students and is held in English.

SSPA 2017 will focus on “Advanced Analytical Methodologies for Biotechnological and Biological medicinal products”. SSPA will start with a regulatory session, followed by four main sessions concerning:

  • Analytical methods in ADMET studies
  • ADMET studies of small molecules
  • ADMET studies of large biologics
  • Case studies

SSPA 2017 participants can choose between two registration packages: an all inclusive registration or a basic registration, the latter does not include accommodation. Deadline for registration: June 15th

The list of confirmed speakers, as well as information on registration and abstract submission can be found on the SSPA 2017 website:

Please keep in mind that immediately following SSPA there will be the 17th International Meeting on "Recent Developments in Pharmaceutical Analysis" (RDPA2017):

For more information please contact:

Giancarlo Aldini
Tel: +39 02 50319296

EFMC Job Portal

In a continuous effort to improve our services for the Medicinal Chemistry community, the EFMC website offers the opportunity to post, for free, advertisements for any Med Chem related positions, both in industry and in academia.

The available jobs are advertised on the home page of the EFMC (, and in our monthly newsletter “MedChemWatch”. We hope to make the EFMC Job Portal an important tool for both people seeking jobs, and for companies ooking to attract the right candidate.

We strongly encourage you to make use of the opportunity the EFMC is offering to reach through the wider MedChem community.

  • To submit a job offer, please follow this link.
  • To consult the list of available job, please follow this link.

Please share this with those responsible for recruitment in your organisations.

The EFMC Job Portal also links to the job portal of each EFMC Corporate Members, and to the job portal of some of its National Adhering Organisations. If you would like to have your job portal announced, please contact the Secretariat at

EFMC Grants to attend the EFMC-ASMC'17

Every year, the EFMC funds grants for its events with the aim to support the participation of young academic scientists. The full list of events, application conditions and application form can be found on the website

  • The EFMC Grants to attend the EFMC-ASMC'17 have been awarded to:
  • Marta Barniol-Xicota (University of Barcelona, Spain)
  • Carolina Dos Santos Vinagreiro (University of Coimbra, Portugal)
  • Joanna Fedorowicz (Medical University of Gdansk, Poland)
  • Markus Hartmann (Goethe University Frankfurt, Germany) 
  • Josa-Cullera Laia (University of Oxford, United Kingdom)
  • Giulia Rainoldi (Università degli Studi di Milano, Italy)
  • Silvia Serra (Université Paris Saclay, France)
  • Tamara Smidlehner (Ruer Boškovi Institute, Croatia)
  • Steven Verlinden (Vrije Universieit Brussels, Belgium)

Covering the full registration fee to attend the upcoming EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC'17) and the 4th edition of the Young Medicinal Chemists Symposium (EFMC-YMCS 2017), Vienna, Austria – August 27-September 1, 2017.

K4DD Meeting - Binding kinetics: Time is of the essence

After five successful years of the K4DD project, we want to look back with the scientific community to past and future achievements. Therefore, the EU-IMI consortium K4DD will organize an open scientific meeting called "Binding kinetics: Time is of the essence". This, exciting three-day event will be hosted by K4DD coordinator Bayer in Berlin, from Monday 16 till Wednesday 18 October.

The meeting offers an interesting programme with highly renowned speakers such as Piet van der Graaf (Leiden University) and Ron Dror (Stanford University). During this event we will discuss different aspect of drug-target binding kinetics in drug discovery: from assay development to computational approaches.

General information Location: Berlin        
Organization: Bayer, in collaboration with other partners Size: 120-170 participants
Audience: For both K4DD members and external scientists
Date: 16-18 Oct 2017
Length: 2.5 days of which 1/2 day is internal Registration is free of charge
Accommodation and Travel cost are at own expenses

Click here for the preliminary program

If you enjoyed or missed out on the opportunity to attend the 13th EFMC Short Course on Medicinal Chemistry - A Matter of Time: A Kinetic Perspective on Drug-Target Interactions – you will be interested in this event.


Discover the EFMC’s Adhering Organisations: The Division Medicinal Chemistry of the Royal Netherlands Chemical Society (KNCV)

The Division Medicinal Chemistry, in Dutch Sectie Farmacochemie (Section Farmacochemistry), is one of the 17 field divisions of the Royal Netherlands Chemical Society (KNCV) and belongs with approximately 275 members to the medium size divisions. But according to the KNCV it is one of the most active divisions!

The board, consisting of 8-9 members including a student-member, is a mix of people from academia and industry with a background in ‘farmacochemistry’ as defined in the EFMC paper Position Paper ‘What is Medicinal Chemistry’. The board members are elected by the members for a maximum of two terms of 3 years and are primarily responsible for the organisation of scientific meetings and administering awards.

The key meeting is the spring symposium, annually hold by the end of March. The subjects of this one-day symposium usually alternate from a specific topic to medicinal chemistry in a broader sense and are presented by international and national speakers. Since 5 years the meeting is internationally marketed as an EFMC sponsored event, and it attracts on average 90 participants.

Another annual meeting is the medicinal chemistry session organised within the bigger framework of the FIGON Dutch Medicine Days. On the first Monday in October PhD students/post-docs and an industry affiliate of a new small company have the opportunity to present their research. The best oral communication and best poster are awarded with prizes of € 500 and € 250, respectively. Moreover, the winner is the Dutch delegate for a presentation at the EFMC Young Medicinal Chemist Symposium.

The division also participates in the organisation of a focus session at CHAINS, the central and largest Dutch chemistry congress, and supports local meetings and courses.

The Division administers via an international jury a biennial award for the best Dutch PhD thesis in the field, a prize of € 1000 and a statuette with a certificate. The award ceremony is at the spring symposium where the winner presents a lecture about the work.

Organised and upcoming events 2017:

  • Spring symposium ‘Small molecules and biologicals in cancer immunotherapy’, 17th March 2017, Utrecht, The Netherlands.
  • Biennial award ceremony Dutch Medicinal Chemistry Prize, 17th March 2017, Utrecht, The Netherlands.
  • Session Medicinal Chemistry at the FIGON Dutch Medicines Days, 2nd October, Ede, The Netherlands.
  • Focus session ‘Translational Chemistry’ at CHAINS2017, 5th-7th December, Veldhoven, The Netherlands.

News from the Division of Medicinal Chemistry & Chemical Biology (DMCCB) of the Swiss Chemical Society

We are pleased to invite you to the SCS Fall Meeting 2017 (August 21-22, 2017 – Bern, Switzerland), the largest annual scientific event held in Switzerland. Given its increased size and popularity, the meeting was extended to an event of one and a half days to better accommodate the one thousand participants, and to also offer new platforms. We are happy and proud to present a fantastic and diversified program with contributions from academia and industry in all fields of chemistry.

The SCS Fall Meeting offers a unique opportunity for all members of the community to share the results of their research initiatives. It also stimulates the exchange of ideas between all generations of chemists, often creating the seeds for new projects and collaborations.

Highlights of the first day, Aug 21, 2017, will be

The second day, Aug 22, 2017, will provide you the traditional Fall Meeting program with

Topics of the parallel sessions are

  • Analytical sciences
  • Catalysis science & engineering
  • Inorganic & coordination chemistry
  • Medicinal chemistry & chemical biology
  • Organic chemistry
  • Physical chemistry
  • Polymers, colloids & interfaces
  • Computational chemistry => will take place in Basel on the occasion of the 'Symposium für Theoretische Chemie (STC)'.

Prof. Silvio Decurtins, University of Bern and Chair of the FM'17
Dr. Hans P. Lüthi, ETH Zürich and vice chair of the FM'17
Prof. Roger Alberto, University of Zürich and DFR President
Dr. Alain De Mesmaeker, Syngenta and SCS President
David Spichiger, SCS Executive Director

For more information please see:

News From the Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC)

The BMCS is announcing the following meetings:

  • 19th Cambridge Medicinal Chemistry Symposium, 10th-13th September 2017, Churchill College, Cambridge, UK
  • 2nd RSC/SCI Fibrosis Medicinal Chemistry Conference, 10th November 2017, SCI, London, UK

19th Cambridge Medicinal Chemistry symposium, 10th-13th September 2017, Churchill College, Cambridge, UK

The call for poster abstracts will close on 21st July

Synopsis:   Reflecting current trends in medicinal chemistry and pharmaceutical research, the scientific programme will feature lectures on the full range of drug targets, key enabling processes and technologies together with late breaker talks.  Furthermore, one session will be dedicated to neglected tropical diseases including a planned live webcast that will be recorded for further distribution.


2nd RSC / SCI Fibrosis Medicinal Chemistry conference, 10th November 2017, SCI, London, UK

Synopsis:  Fibrosis disease is the result of a dysregulated wound healing process and is responsible for considerable patient mortality affecting multiple organs in diseases such as idiopathic pulmonary fibrosis (IPF), diabetic nephropathy, steatohepatitis and systemic sclerosis. Fibrosis disease pathology is often complex and this inaugural symposium on fibrosis will provide mechanistic insight and progress in medicinal chemistry and drug discovery from experts across the world.

Website:  not yet available

News from EuCheMS

Dear colleagues,

On May 10 2017, a very well attended workshop in the European Parliament on scientific aspects of glyphosate, which was jointly organised by Pavel Poc, MEP, EuCheMS and ECTN. It provided rich scientific views from complementary subfields of chemistry, statistics, ethics and including also a historical overview since 1970’s. Speakers noted that, amongst other, there is not enough scientific evidence available to make reliable conclusions, also harmonisation of current methodologies is missing.

Issue 5 of MedChemComm is available!

Download the issue 5 of MedChemComm, the official journal of EFMC, here.




Founded in 2001, GalChimia has become the Spanish leader in synthetic organic chemistry. Our expert, dedicated team of chemists has found a productive outlet for their obsession with chemistry, providing services to clients worldwide.

More info


September 6-7, 2018
Ljubljana, Slovenia
5th EFMC Young Medicinal Chemist Symposium (EFMC-YMCS 2018)


June 22, 2018
Madrid, Spain
V SEQT Young Researchers Symposium

June 27, 2018
Dublin, Ireland
2nd Medicinal Chemistry Ireland Conference

November 12-13, 2018
London, United Kingdom
2nd SCI/RSC Symposium on Antimicrobial Drug Discovery



September 19-21, 2018
Rimini, Italy
Summer School in Pharmaceutical Analysis (SSPA)

October 7-12, 2018
Leysin, Switzerland
13th Swiss Course on Medicinal Chemistry


Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom

Read more

MsC student or PhD internship, KU Leuven: Cellular and Molecular Medicine, Leuven, Belgium

Read more

Find us on social media

EFMC Facebook EFMC Twitter EFMC LinkedIn EFMC Instagram